Cardiac ablation system with pulsed aiming light

• US 8,696,653 B2
• Filed: 10/01/2010
• Issued: 04/15/2014
• Est. Priority Date: 10/02/2009
• Status: Active Grant

• Current Assignee: Cardiofocus Incorporated
• Original Assignee: Cardiofocus Incorporated
• Inventors: Melsky, Gerald, Ostrowski, Susan
• Primary Examiner(s): Thomson, Bill
• Assistant Examiner(s): PAHAKIS, MANOLIS Y
• Application Number:
  US12/895,969
• Publication Number:
  US 20110082449A1
• Time in Patent Office: 1,292 Days
• Field of Search: 606/14, 600/178
• US Class Current: 606/14
• CPC Class Codes: A61B 18/24 with a catheter A61B18/26, A61B18/28 take precedence
• CPC Class Codes: A61B 2017/22051 with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation A61B2017/22048, A61B2017/3486 take precedence
• CPC Class Codes: A61B 2017/22059 transparent
• CPC Class Codes: A61B 2018/2025 with a pilot laser
• CPC Class Codes: A61B 2090/3618 with a mirror
• CPC Class Codes: A61B 90/361 Image-producing devices, e.g. surgical cameras

Abstract

An apparatus and method for treating a cardiac condition with visual inspection of a tissue treatment site includes the step of delivering an expanding member formed on a distal end of a catheter to a position adjacent a tissue treatment area within a patient'"'"'s heart. The expandable member has an elastic portion configured to conform to the tissue treatment area. The method further includes the steps of expanding the expandable member thereby allowing the elastic portion of the expandable member to conform to the tissue treatment area and positioning an energy emitter at a first location within an inner lumen of the catheter. A visible aiming beam is projected during positioning of the energy emitter and ablative energy is delivered from the energy emitter to the tissue treatment area thereby resulting in a first spot lesion. The ablative energy is coincident with the aiming beam and the aiming beam is in the form of pulsed visible light to allow intermittent visual inspection of the first spot lesion at times when the aiming beam is not projected onto the tissue treatment area, thereby allowing visual inspection of the ablative characteristics and sufficiency of the first spot lesion.

Claims

1. A cardiac tissue ablation system, comprising:

an elongate catheter configured to deliver a distal end thereof to a patient'"'"'s heart;

an expandable member formed at the distal portion of the catheter, the expandable member having an elastic portion configured to conform to the shape of a target tissue region upon expansion;

an energy emitter movably disposed within a lumen of the catheter, the energy emitter configured to deliver radiant ablative energy to the target tissue region;

an aiming light source configured to emit a pulsed yellow aiming light during delivery of the radiant ablative energy which is invisible, the pulsed yellow aiming light being coincident and coaxial with the radiant ablative energy and being composed of a discrete red wavelength component configured to be reflected by both blood and tissue and a discrete green wavelength component configured to be reflected only by tissue, so that a location of the aiming light is always visible irrespective of whether the aiming light is directed at blood or tissue and a presence of blood in a projected path of the radiant ablative energy is detectable by observing that at least a portion of a reflection of the pulsed aiming light comprises the red wavelength component and not the green wavelength component;

an endoscope configured to allow direct visualization of the tissue treatment area; and

at least one illumination source that is separate and distinct and spaced from both the endoscope and the energy emitter, the illumination source being located behind a distal end of the endoscope and configured to illuminate the tissue treatment area in a manner in which the illumination source lies outside a field of view of the endoscope, the illumination source being configured to provide backlighting for the endoscope and to emit an illumination light, wherein the pulsed yellow aiming light is configured to be visually distinguishable from the illumination light.

2. The system of claim 1, wherein the energy emitter is configured such that spots of energy result in a series of lesions formed in the target tissue region when the emitter is activated.

3. The system of claim 2, wherein the energy emitter is configured to form arc shaped lesions in the target tissue region.

4. The system of claim 1, wherein the energy emitter is slidably and rotatably disposed within an inner lumen of the catheter thereby allowing the energy emitter to effectively ablate any of a plurality of regions within the target tissue area.

5. The system of claim 1, wherein the expandable member includes a plurality of markers defining a number of power-level segments, each power-level segment corresponding to an amount of ablation energy to be delivered to the segment by the energy emitter.

6. The system of claim 5, that further includes at least one radiopaque marker visible via x-ray imaging shaped in such a manner as to allow the determination of the rotational orientation of the expandable member relative to the patients anatomy.

7. The system of claim 1, wherein the expandable member is a blunt-nosed balloon configured to impede passage of the balloon into a pulmonary vein when the balloon is deployed in proximity to the vein.

8. The system of claim 1, wherein the expandable member is a balloon with a tapered distal end that impedes passage of the balloon into a pulmonary vein when the balloon is deployed in proximity to the vein.